Related Experiment Video
Updated: Nov 4, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Insulin as a Tool in Factitious Dysglycemia
Samih A Odhaib1, Qussay N Almaliki2, Abbas A Mansour3
1Adult Endocrinology, Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) College of Medicine, University of Basrah, Basrah, IRQ.
Factitious dysglycemia, self-inflicted harm to feign illness for empathy, is explored in three Iraqi women. Cases involved insulin misuse or omission, leading to dangerous blood sugar levels, highlighting psychological distress.
Area of Science:
- Endocrinology
- Psychiatry
- Medical Case Studies
Background:
- Factitious dysglycemia involves intentional self-harm to induce abnormal blood glucose levels (hypoglycemia or hyperglycemia) for psychological gain, often seeking attention or empathy.
- This behavior is a form of self-inflicted harm, presenting complex diagnostic and management challenges in clinical practice.
Observation:
- This case series details three Iraqi women presenting with factitious dysglycemia.
- Two women intentionally induced hypoglycemia using insulin to regain family affection.
- A third woman with type 1 diabetes mellitus deliberately omitted insulin, leading to diabetic ketoacidosis and repeated hospitalizations for familial attention, with underlying suicidal ideation.
Findings:
- Thorough patient history, physical examination, and family involvement were crucial in uncovering the underlying factitious behavior.
- The diverse motivations behind factitious dysglycemia, including seeking affection and attention through illness, were identified.
Implications:
- These cases underscore the importance of considering factitious disorders in patients with unexplained glycemic abnormalities.
- Prompt psychiatric referral and management are essential for addressing the psychological underpinnings of factitious dysglycemia.
- This series represents the first documented cases of factitious dysglycemia from Iraq, contributing to a broader understanding of the condition in diverse cultural contexts.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Glinides

